Saint Joseph Mercy Brighton

Az itteni vizsgálatok

Miről szól a helyszín 38 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Tüdőrák13 vizsgálat
• Gyermekkori daganatok6 vizsgálat
• Prosztatarák4 vizsgálat
• Vastagbélrák4 vizsgálat
• Áttétes emlőrák3 vizsgálat
• Hólyagrák3 vizsgálat
• Hasnyálmirigyrák2 vizsgálat
• Mielóma multiplex2 vizsgálat
• Tripla negatív emlőrák2 vizsgálat
• Elhízás1 vizsgálat
• Glioblasztóma1 vizsgálat
• Krónikus mieloid leukémia (CML)1 vizsgálat
• és még 4

Fázis

• 3. fázis18 vizsgálat
• 2. fázis14 vizsgálat
• 2/3. fázis2 vizsgálat

Állapot

• Fut, nem toboroz21 vizsgálat
• Lezárult11 vizsgálat
• Toboroz3 vizsgálat
• Felfüggesztve1 vizsgálat
• Leállították1 vizsgálat
• Visszavonták1 vizsgálat

Fő szponzor

• SWOG Cancer Research Network19 vizsgálat
• Alliance for Clinical Trials in Oncology9 vizsgálat
• ECOG-ACRIN Cancer Research Group6 vizsgálat
• GOG Foundation1 vizsgálat
• National Heart, Lung, and Blood Institute (NHLBI)1 vizsgálat
• és még 2

Futó vizsgálatok

• Toboroz

  Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  NCT05561387· 3. fázis· SWOG Cancer Research Network· Forrás

  Contact: Elie G. Dib (principal investigator)

• Fut, nem toboroz

  Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

  NCT05633602· 3. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

  NCT05241860· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy

  NCT04637594· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT05096663· 2/3. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

  NCT04455750· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

  NCT04533451· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

  NCT04233866· 2. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)

  NCT04268550· 2. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

  NCT04094688· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery

  NCT03757949· 3. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia

  NCT03654768· 2. fázis· SWOG Cancer Research Network· Forrás

• Toboroz

  Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  NCT03678025· 3. fázis· SWOG Cancer Research Network· Forrás

  Contact: Christopher M. Reynolds (principal investigator)

• Toboroz

  S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

  NCT03723928· SWOG Cancer Research Network· Forrás

  Contact: Christopher M. Reynolds (principal investigator)

• Fut, nem toboroz

  Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

  NCT03516942· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  Breast Cancer WEight Loss Study (BWEL Study)

  NCT02750826· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

  NCT02785952· 3. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

  NCT02595424· 2. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

  NCT02445391· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  NCT02488967· 3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

  NCT02201992· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

  NCT01863550· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  S0820, Adenoma and Second Primary Prevention Trial

  NCT01349881· 3. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

  NCT00499330· Alliance for Clinical Trials in Oncology· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Áttétes emlőrák1 toboroz
• Gyermekkori daganatok1 toboroz
• Mielóma multiplex1 toboroz
• Prosztatarák1 toboroz

Lezárt vizsgálatok

• Leállították

  Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

  NCT04871529· 2. fázis· SWOG Cancer Research Network· Forrás

• Visszavonták

  Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

  NCT05364645· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

  NCT04173507· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

  NCT03971474· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT03845296· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

  NCT03475186· 2. fázis· Wake Forest University Health Sciences· Forrás

• Lezárult

  Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast Cancer

  NCT03633331· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Lezárult

  S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

  NCT03365882· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  The National Myelodysplastic Syndromes (MDS) Study

  NCT02775383· National Heart, Lung, and Blood Institute (NHLBI)· Forrás

• Lezárult

  S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

  NCT02438722· 2/3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

  NCT01809691· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

  NCT01101451· 3. fázis· GOG Foundation· Forrás

• Lezárult

  Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

  NCT00632853· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás